EDRIENA

Lupin Limited

Application Filed: 2018-06-29
Trademark Application Details
Trademark Logo EDRIENA

Mark For: EDRIENA™ trademark registration is intended to cover the categories of pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation. [all]

Status

2021-07-19 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88020915
Mark Literal ElementsEDRIENA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-07-30
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameRobert L Powley
Attorney Docket Number390.113(US-3
Law Office AssignedM70
Employee NameCROWLEY, SEAN MICHAEL

Timeline

2018-06-29Application Filed
2019-06-04Published
2019-06-04Published for Opposition
2019-07-30Location: INTENT TO USE SECTION
2019-10-18Status: Live/Pending
2019-10-22Transaction Date
2021-06-25Status: A fourth request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Lupin Limited
AddressBandra Kurla Complex -- Bandra (W) B/4 Laxmi Towers Mumbai INDIA 400051
Legal Entity TypeLimited Company (ltd.)
Legal Entity StateINDIA

Documents

DrawingJPEG2018-06-29
TEAS RF New ApplicationMULTI2018-06-29
Notation to FileXML2018-10-27
Offc Action OutgoingXML2018-10-27
XSearch Search SummaryXML2018-10-27
XSearch Search SummaryXML2018-10-27
TRAM Snapshot of App at Pub for OppostnMULTI2019-04-18
Publication & Issue Review CompleteMULTI2019-05-02
Notice of PublicationXML2019-05-15
Notification Of Notice of PublicationXML2019-05-15
OG Publication ConfirmationAPPLICATION/XML2019-06-04
Notice of AllowanceXML2019-07-30
Extension of Time to File SOUXML2019-10-18
ITU Extension ApprovalXML2019-10-22
ITU Unit ActionMULTI2019-10-22
Extension of Time to File SOUXML2020-06-04
ITU Extension ApprovalXML2020-06-06
ITU Unit ActionMULTI2020-06-06
Extension of Time to File SOUAPPLICATION/XML2020-12-17
ITU Extension ApprovalXML2020-12-19
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-12-19
Extension of Time to File SOUAPPLICATION/XML2021-06-25
ITU Extension ApprovalAPPLICATION/XML2021-06-29
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2021-06-29

Attorney of Record

ROBERT L POWLEY
POWLEY & GIBSON P.C.
SUITE 2203
60 HUDSON ST.
NEW YORK NY 10013

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-06-29
TEAS EXTENSION RECEIVED2021-06-25
EXTENSION 4 GRANTED2021-06-2598765
EXTENSION 4 FILED2021-06-2598765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-12-19
TEAS EXTENSION RECEIVED2020-12-17
EXTENSION 3 GRANTED2020-12-1798765
EXTENSION 3 FILED2020-12-1798765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-06-06
TEAS EXTENSION RECEIVED2020-06-04
EXTENSION 2 GRANTED2020-06-0498765
EXTENSION 2 FILED2020-06-0498765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-10-22
TEAS EXTENSION RECEIVED2019-10-18
EXTENSION 1 GRANTED2019-10-1898765
EXTENSION 1 FILED2019-10-1898765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-07-30
PUBLISHED FOR OPPOSITION2019-06-04
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-06-04
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-05-15
LAW OFFICE PUBLICATION REVIEW COMPLETED2019-05-0168552
ASSIGNED TO LIE2019-04-2968552
APPROVED FOR PUB - PRINCIPAL REGISTER2019-04-17
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-10-276325
NON-FINAL ACTION WRITTEN2018-10-2781853
NON-FINAL ACTION E-MAILED2018-10-276325
ASSIGNED TO EXAMINER2018-10-2081853
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-07-05
NEW APPLICATION ENTERED IN TRAM2018-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed